The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Plasma Homocysteine Predicts Mortality Independently of Traditional Risk Factors and C-Reactive Protein in Patients With Angiographically Defined Coronary Artery Disease
Open accessAbstract
Background —Plasma homocysteine (tHCY) has been associated with coronary artery disease (CAD). We tested whether tHCY also increases secondary risk, after initial CAD diagnosis, and whether it is independent of traditional risk factors, C-reactive protein (CRP), and methylenetetrahydrofolate reductase ( MTHFR ) genotype. Methods and Results —Blood samples were collected from 1412 patients with severe angiographically defined CAD (stenosis ≥70%). Plasma tHCY was measured by fluorescence polarization immunoassay. The study cohort was evaluated for survival after a mean of 3.0±1.0 years of follow-up (minimum 1.5 years, maximum 5.0 years). The average age of the patients was 65±11 years, 77% were males, and 166 died during follow-up. Mortality was greater in patients with tHCY in tertile 3 than in tertiles 1 and 2 (mortality 15.7% versus 9.6%, P =0.001 [log-rank test], hazard ratio [HR] 1.63). The relative hazard increased 16% for each 5-μmol/L increase in tHCY ( P <0.001). In multivariate Cox regression analysis, controlling for univariate clinical and laboratory predictors, elevated tHCY remained predictive of mortality (HR 1.64, P =0.009), together with age (HR 1.72 per 10-year increment, P <0.0001), ejection fraction (HR 0.84 per 10% increment, P =0.0001), diabetes (HR 1.98, P =0.001), CRP (HR 1.42 per tertile, P =0.004), and hyperlipidemia. Homozygosity for the MTHFR variant was weakly predictive of tHCY levels but not mortality. Conclusions —In patients with angiographically defined CAD, tHCY is a significant predictor of mortality, independent of traditional risk factors, CRP, and MTHFR genotype. These findings increase interest in tHCY as a secondary risk marker and in secondary prevention trials (ie, with folate/B vitamins) to determine whether reduction in tHCY will reduce risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Vitamin Status and Intake as Primary Determinants of Homocysteinemia in an Elderly Population
Selhub, J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510220049033 · Cited by 1,972
Greenland (2000) · doi:10.1161/01.cir.101.1.e16 · Cited by 924
Cited by
MTHFR 677C→T Polymorphism and Risk of Coronary Heart Disease: A Meta-analysis
Klerk, M., Verhoef, P., Clarke, R., Blom, H. J., Kok, F. J., Schouten, E. G., & and the MTHFR Studies Collaboration Group (2002) · JAMA · doi:10.1001/jama.288.16.2023 · Cited by 934
High-sensitivity C-reactive proteinClinical importance
BASSUK, S., RIFAI, N., & RIDKER, P. (2004) · Current Problems in Cardiology · doi:10.1016/s0146-2806(04)00074-x · Cited by 464
Bazzano, L. A., He, J., Muntner, P., Vupputuri, S., & Whelton, P. K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-11-200306030-00010 · Cited by 407
The Hordaland Homocysteine Studies
Ueland, P. M., Nygård, O., Vollset, S. E., & Refsum, H. (2001) · Lipids · doi:10.1007/s11745-001-0679-7 · Cited by 328
Doshi, S. N., McDowell, I. F. W., Moat, S. J., Payne, N., Durrant, H. J., Lewis, M. J., & Goodfellow, J. (2002) · Circulation · doi:10.1161/hc0102.101388 · Cited by 324
Metadata
- Authors
- Anderson, J. L., Muhlestein, J. B., Horne, B. D., Carlquist, J. F., Bair, T. L., Madsen, T. E., & Pearson, R. R.
- Venue
- Circulation
- Published
- 2000-09-12
- Volume
- 102
- Issue
- 11
- Pages
- 1227-1232
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2143536962
- Cited by
- 234
- References
- 3
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.